Moderate riskFDA DrugClass II

Appco Pharma prazosin capsules recalled for nitrosamine impurity

Appco Pharma LLC is recalling specific lots of prazosin hydrochloride 2mg capsules because they contain higher-than-allowed levels of a nitrosamine impurity called N-nitroso-prazosin. Nitrosamines are chemicals that may increase cancer risk with long-term exposure. No injuries have been reported so far.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your prazosin matches one of the recalled lot numbers (2404153UC, 2404154UC, 2502055UC, 2505173UC, or 2505175UC).
  2. Do not stop taking prazosin without talking to your doctor first.
  3. Contact your pharmacy or doctor to get a replacement or alternative medication.
  4. Call Biocon Pharma at 1-833-BIOCON1 or the FDA MedWatch line at 1-888-SAFEMEDS if you have questions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
58,896 bottles- 100's count
Illnesses reported
None reported
Manufactured in
262 Old New Brunswick Rd Ste N, Piscataway, NJ, United States
Classification
Class II
Recall number
D-0420-2026

In the FDA's words

Description
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY. Distribution: U.S.A. Nationwide Affected quantity: 58,896 bottles- 100's count
Hazard
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

3 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

Industrial chemicalsOtherDrugsSold nationwideMore from FDA Drug